Lower Number of Fludarabine Cycles in Patients with Lymphoid Malignancies
Fludarabine, a nucleoside analog, is commonly used to treat lymphoid malignancies. While the optimal number of cycles of fludarabine per treatment course is not known, common strategies include treatment for 6 cycles or 2-3 cycles past best or complete response. This study is a retrospective revie...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2014-08-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://mjhid.org/index.php/mjhid/article/view/1810 |